A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity Academic Article uri icon

Overview

MeSH Major

  • Chemotherapy, Cancer, Regional Perfusion
  • Melanoma
  • Sarcoma
  • Skin Neoplasms

abstract

  • ILI is well tolerated. Half of the patients experienced a complete or partial response.

publication date

  • August 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1245/ASO.2006.05.003

PubMed ID

  • 16791448

Additional Document Info

start page

  • 1123

end page

  • 9

volume

  • 13

number

  • 8